Dissolution Apparatus 3 & 4 (Reciprocating cylinder & Flow through cells)

Apparatus: - 3 (Reciprocating Cylinder)


Reciprocating cyliner

Apparatus:-
Consists of a set of set of cylindrical, flat bottomed glass vessels; a set of glass reciprocating cylinders; SS fittings & screen that are made of suitable material; and a motor & drive assembly to reciprocate the cylinders.
No part of the assembly, including the environment in which the assembly is placed, contributes significant motion, agitation or vibration beyond that due to the smooth, vertically reciprocating cylinders.
Reciprocation should be at the tolerance of ± 5% at a distance of 9.9 to 10.1 cm.
Apparatus suitability test:-
Reference standards:-
  • USP Chlorpheniramine extended  release tablets RS (For single unit drug release)
  • USP Theophylline extended release beads RS (For multiple units).


Dissolution Medium:-Proceed as directed earlier.
Procedure:-
  • Place the stated volume of dissolution medium in each vessel of the apparatus.
  • Assemble & equilibrate the medium to 37 ±0.5°, and remove the thermometer.
  • Place one dosage form in each cylinder and operate the apparatus.
  • When capsule shell interfere with the analysis, remove the content of not less than 6 capsules as completely as possible, and dissolve the empty capsule shell in the specified volume of the dissolution medium.

 Time and Interpretation: - Proceed as directed earlier.

Apparatus:-4   (Flow through cells)

flow through cell

Apparatus:-

Apparatus consists of:  reservoir, pump, a flow through cell, water bath.
The cell size specified in the individual monograph.
Pump delivery—240 & 960ml/hr with standard flow rates of 4,8,16 ml per minute.
Flow must be volumetric and sinusoidal at a pulsation rate of 120 + 10 pulses per minute. Standard cell diameter are 12 & 22.6 mm, the bottom cone  is filled with small glass beads of about 1 mm. diameter with one bead of about 5 mm. positioned at the apex to protect the fluid entry tube.
  • A Tablet holder.
  • O Rings for fixation of apparatus.

The cell is immersed in medium& temp is maintained at 37±0.5°

Apparatus suitability & Dissolution medium:- 
As directed under apparatus 1 & 2.

Procedure:-
  • Place glass beads in to the cell & 1 dosage form unit on top of the beads or on a wire carrier.
  • Introduce the dissolution medium through the bottom of the cell to obtain specified floe rate with an accuracy of 5%.
  • When capsule shell interfere with the analysis, remove the content of not less than 6 capsules as completely as possible, and dissolve the empty capsule shell in the specified volume of the dissolution medium.
  • Make any necessary correction. Correction factor greater than 25% of the labeled content is unacceptable. 

 Time & Interpretation: - Proceed as directed under apparatus 1 & 2.

Flow through cell (E. P.).
Procedure:-
  • Place one unit of the preparation to be examined in chamber A. Close the cell with the prepared filtered assembly.
  • Heat the dissolution medium to an appropriate temp. By considering M.P. point of the preparation.
  • Using pump, introduce warm dissolution medium through the bottom of the cell to obtain a suitable continuous flow through an open or closed circuit at the prescribed rate.
  • The preparation spreads through the dissolution medium according to its physico-chemical properties. Large volume suppositories may be tested.


Delayed Release (Enteric coated) articles.
Use method A or B and the apparatus specified in the individual monograph.
Apparatus suitability test: - As directed earlier.

METHOD: - A
Procedure:-
  • Acid Stage: - Place 750 ml of 0.1N HCl in the vessel. Operate the apparatus for 2 hrs. And withdraw sample.
  • Continue testing through all the levels unless the results of both acid and buffer stages conform at an earlier level.
  • Quantity of the active ingredient dissolved from the units tested confirm to Acceptance table given below.

Level
No. Tested
Criteria
A1
6
No individual value exceeds 10% dissolved
A2
6
Average of the 12 units (A1+A2) is not more than 10 % dissolved, no individual unit is greater than 25 % dissolved
A3
12
Average of the 24 units (A1+A2+A3) is not more than 10% dissolved, and no individual unit is greater than 25% dissolved.

Method B:- 
  • Acid Stage: 1000ml 0.1 N HCL and operate for 2hrs.
  • Buffer Stage: Use buffer that previously has been equilibrated to a temp. of 370+0.50
  • Add 1000ml of pH 6.8+0.05 phosphate buffer, prepared by mixing 0.1N HCL with 0.02M tribasic sodium phosphate (3:1)
  • Operate for 45 min.

Interpretation: - Proceed as directed in Method A

Comments

Post a Comment

Popular posts from this blog

PLANT LAYOUT FOR CAPSULE MANUFACTURING DEPARTMENT & MANUFACTURING PROCESS

Image
PLANT LAYOUT  FOR CAPSULE MANUFACTURING DEPARTMENT: ENVIRONMENT CONDITION FOR CAPSULE FILLING AREA Humidity:          Not more than 35% RH Temperature:    Not more than 25% Area of each room, position of equipments, washing, drying, and sanitary facilities must be in accordance with GMP. MANUFACTURING PROCESS: CHEMCAPS Limited is an India based young and dynamic organization engaged in the manufacture and export of 'empty hard gelatin capsules' under the brand name of 'Chemlock' for discerning customers around the globe. COMPOSITION                                     Gelatin                                     Water                                     Colorants                                     Opecifier (TiO2 Dyes and Other)                                     Preservative MANUFACTURING OF HGC SHELL: SFR-901 FULLY AUTOMATIC CAPSULE MACHINE: FEATURES OF SFR-901 Ø   The Safrroys SFR-901 mod
Keep reading

ANTIOXIDANTS: In Pharmaceutical Formulation

Image
Introduction: Chemically they are reducing agents. They oxidize themselves and prevent oxidation of API. A substance that inhibits oxidation is called antioxidants. The effectiveness of antioxidant can depend on the concentration used and pH of solution. Examples:  Ascorbic acid,  butylated hydroxy anisole (BHA),  butylated hydroxyl toluene (BHT) Oxidation is a chemical reaction involving the loss of electrons or an increase in oxidation state. Oxidation reactions can produce free radicals. In turn, these radicals can start chain reactions. When the chain reaction occurs in a cell, it can cause damage or death to the cell. Antioxidants terminate these chain reactions by removing free radical intermediates, and inhibit other oxidation reactions. The following are some of the qualities of an ideal anti-oxidant: It should be readily soluble or dispersible in the medium. It should be effective in low concentration. It should be non-toxic. It should be non-irrita
Keep reading

3. Development of working hypothesis:

Image
After extensive literature survey, researcher should state in clear terms the working hypothesis or hypotheses. Working hypothesis is tentative assumption made in order to draw out and test its logical or empirical consequences. As such the manner in which research hypotheses are developed is particularly important since they provide the focal point for research. They also affect the manner in which tests must be conducted in the analysis of data and indirectly the quality of data which is required for the analysis. In most types of research, the development of working hypothesis plays an important role. Hypothesis should be very specific and limited to the piece of research in hand because it has to be tested. The role of the hypothesis is to guide the researcher by delimiting the area of research and to keep him on the right track. It sharpens his thinking and focuses attention on the more important facets of the problem. It also indicates the type of data required
Keep reading

Facebook Page

Knowledge of Pharma